Actively Recruiting
A Prospective Observational Study Evaluating the Safety and Performance of TSX Dental Implants for Tooth Loss in the Upper or Lower Jaw
Led by ZimVie · Updated on 2026-07-28
62
Participants Needed
2
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a prospective, observational, multicenter study to evaluate the safety, effectiveness, and clinical performance of the TSX dental implant system in patients needing implants in the upper or lower jaw maxilla or mandible. This study involves 62 implants placed in approximately 60 patients who require dental implants to treat tooth loss, excluding those with prior implant failures or major bone grafting needs. The study aims to observe implant integration success and survival over a 2-year period. Participants will receive dental implants using the TSX dental implant system, with temporary prostheses placed either immediately during the implant surgery or within 48 hours, or between 3 to 16 weeks after implant placement. Final restorative treatments using the full range of ZimVie prosthetic systems will be completed no later than 4 months following implant surgery. All implants and restorations will be monitored yearly for 2 years. During the study, participants will attend follow-up visits yearly for 2 years to assess implant integration, survival, and changes in bone levels around the implant sites. Evaluations will include clinical examinations and imaging to measure bone regression and implant stability. Participants must agree to be evaluated at each study visit and provide informed consent. Total participation spans from implant placement surgery through the 2-year follow-up.
CONDITIONS
Brief Title
A Clinical Study of the TSX Dental Implant System (Xpresso)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients at least 18 years of age
- Decision already made to use a dental implant in an edentulous or immediately removed tooth site in the mandible or maxilla
- Sites planned for immediate extraction and restoration should have intact bony walls (Type I sockets); Type II considered by clinician discretion
- Previously extracted sites healed for at least 3-4 months
- Presence of opposing dentition that allows functional occlusion
- Implant site with at least 10mm alveolar bone height and sufficient restorative space, with only minor augmentation if needed
- Physically able to tolerate conventional surgical and restorative procedures
- Signed informed consent provided
- Agreement to be evaluated at each study visit
You will not qualify if you...
- Known uncontrolled systemic diseases such as diabetes, endocrine, heart, immune, or mental disorders
- Current use of bisphosphonates
- Active infection or severe inflammation at treatment areas
- Smoking more than 10 cigarettes per day
- History of therapeutic radiation to the head or jaw
- Pregnant or planning pregnancy within 6 months of enrollment
- Untreated severe parafunctional habits like bruxism or clenching
- Previous dental implant failure at the intended implant site
- HIV or active Hepatitis infection
- History of untreated generalized severe periodontitis
Research Team
H
Hai Bo Wen
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here